OBI — Ondine Biomedical Share News
0.000.00%
- £41.58m
- £40.21m
- CA$1.20m
RCS - Ondine Biomedical - Steriwave deploying in eight new sites
AnnouncementRCS - Ondine Biomedical - Ondine starts first UK health economics study
AnnouncementRCS - Ondine Biomedical - Microbiome research supports use of Steriwave
AnnouncementREG - Ondine Biomedical - Grant of Share Options
AnnouncementRCS - Ondine Biomedical - Ondine unveils new research at SPIE Photonics West
AnnouncementREG - Ondine Biomedical - Appointment of new Chief Financial Officer
AnnouncementREG - AIM - AIM Notice - 15/12/2023
AnnouncementRCS - Ondine Biomedical - C$4.91 raise supports ongoing commercialisation
AnnouncementREG - Ondine Biomedical - TR-1: NOTIFICATION OF MAJOR HOLDINGS
AnnouncementREG - Ondine Biomedical - Result of Fundraising
AnnouncementREG - AIM - AIM Notice - 08/12/2023
AnnouncementREG - Ondine Biomedical - Result of Placing & Broker Option Update
AnnouncementREG - Ondine Biomedical - Close of Bookbuild
AnnouncementREG - Ondine Biomedical - Update. Re investor-led financing
AnnouncementREG - Ondine Biomedical - Ondine announces investor-led financing
AnnouncementREG - Ondine Biomedical - Photodisinfection recommended as Standard of Care
AnnouncementRCS - Ondine Biomedical - Steriwave use expanded following successful pilot
AnnouncementRCS - Ondine Biomedical - 66.5% reduction in spine surgery infection rate
AnnouncementRCS - Ondine Biomedical - Steriwave shown to reduce resistant bacteria
Announcement